Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec;42(6):664-674.
doi: 10.1007/s10930-023-10149-x. Epub 2023 Aug 27.

Molecular Modeling and Optimization of Type II E.coli l-Asparginase Activity by in silico Design and in vitro Site-directed Mutagenesis

Affiliations

Molecular Modeling and Optimization of Type II E.coli l-Asparginase Activity by in silico Design and in vitro Site-directed Mutagenesis

Mahdieh Mahboobi et al. Protein J. 2023 Dec.

Abstract

Introduction: L-asparaginase (also known as L-ASNase) is a crucial therapeutic enzyme that is widely used in treatment of ALL (acute lymphoblastic leukemia) as a chemotherapeutic drug. Besides, this enzyme is used in the food industry as a food processing reagent to reduce the content of acrylamide in addition to the clinical industry. The improvement of activity and kinetic parameters of the L-ASNase enzyme may lead to higher efficiency resulting in practical achievement. In order to achieve this goal, we chosen glycine residue in position 88 as a potential mutation with advantageous outcomes.

Method: In this study, firstly to find the appropriate mutation on glycine 88, various in silico analyses, such as MD simulation and molecular docking, were carried out. Then, the rational design was adopted as the best strategy for molecular modifications of the enzyme to improve its enzymatic properties.

Result: Our in silico findings show that the four mutations G88Q, G88L, G88K, and G88A may be able to increase L-ASNase's asparaginase activity. The catalytic efficiency of each enzyme (kcat/Km) is the most important feature for comparing the catalytic activity of the mutants with the wild type form. The laboratory experiments showed that the kcat/Km for the G88Q mutant is 36.32% higher than the Escherichia coli K12 ASNase II (wild type), which suggests that L-ASNase activity is improved at lower concentration of L-ASN. Kinetic characterization of the mutants L-ASNase activity confirmed the high turnover rate (kcat) with ASN as substrate relative to the wild type enzyme.

Conclusion: In silico analyses and laboratory experiments demonstrated that the G88Q mutation rather than other mutation (G88L, G88K, and G88A) could improve the kinetics of L-ASNase.

Keywords: Catalytic activity; Escherichia coli; In silico; Kinetic characterization; L-asparaginase II; Site-directed mutagenesis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Maggi M, Scotti C (2022) Structural aspects of E. coli type II asparaginase in Complex with its secondary product L-Glutamate. Int J Mol Sci 23(11):5942 - PubMed - PMC - DOI
    1. Wang Y, Xu W, Wu H, Zhang W, Guang C, Mu W (2021) Microbial production, molecular modification, and practical application of L-asparaginase: a review. Int J Biol Macromol 186:975–983 - PubMed - DOI
    1. Van Trimpont M, Peeters E, De Visser Y, Schalk AM, Mondelaers V, De Moerloose B et al (2022) Novel insights on the Use of L-Asparaginase as an efficient and safe anti-cancer therapy. Cancers 14(4):902 - PubMed - PMC - DOI
    1. Wang N, Ji W, Wang L, Wu W, Zhang W, Wu Q et al (2022) Overview of the structure, side effects, and activity assays of l-asparaginase as a therapy drug of acute lymphoblastic leukemia. RSC Med Chem.
    1. Avramis VI, Tiwari PN (2006) Asparaginase (native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukemia. Int J Nanomed 1(3):241

LinkOut - more resources